SITE SEARCH | NEWS | EARNINGS | CALENDARS | MUTUAL FUNDS
Sector Tables: Energy - Retail - Utilities - REIT - Banks - Brokerage - ETFs | Oil Data
Login | Subscribe to Ticker
Market Update : 
GlaxoSmithKline Pressures Europe
Author: Elena Todorova
123jump.com
Last Update: 1:56 PM EDT May 21 2007


(Continued)

Email article | Print article

European stock markets closed mostly in the negative territory Monday, dragged lower by a steep decline in the shares of GlaxoSmithKline and weakness in the bank sector. Shares of pharmaceutical giant GlaxoSmithKline dropped 5% after research showed that diabetes drug Avandia significantly increased cardiovascular risk. The German DAX Xetra 30 added 0.2%, the U.K. FTSE 100 slipped 0.1%, and the French CAC-40 lost 0.2%

 
The rupee advanced to a fresh nine-year high on Monday as investors were inclined to think the Reserve Bank of India would not interfere with the gains of the rupee against the dollar after China widened the yuan''s trading band against the dollar.

The government announced that wheat purchasing in the ongoing Rabi marketing season has crossed 100 lakh tonnes, including more than six lakh tonnes bought by Punjab Government for its own use.

Trading highlights

Reliance Energy was the most active stock with a turnover of Rs 732.30 crore followed by Adlabs and Reliance Capital.

Advancers

Reliance Energy led the gainers, surging 8.5% to Rs 555. Three block deals of 44.10 lakh shares were traded in the stock at an average price of Rs 513 per share in opening trade. Tata Steel soared 5.6% to Rs 624 on fresh buying tracking strong fourth-quarter results announced late last week. Tata Steel had rallied over the past few weeks after the company last month announced attractively priced (Rs 300) rights issue in the ratio of 1:5, and also on hopes of strong fourth quarter results.

Index heavy Reliance Industries surged 3.7% to Rs 1,762. It struck an all-time high of Rs 1,780, on market rumors that it is likely to come out with rights issue. Reliance rejected media reports that the company is likely to miss the June 2008 deadline for commercial production of gas from the Krishna Godavari basin.

ONGC and HDFC Bank rallied over 2.5% each to Rs 933 and Rs 1,100, respectively. ONGC gained after Brent crude oil rose 28 cents to $69.70 a barrel on Monday, May 21 2007, while US benchmark crude gained 20 cents to $65.14, boosted by concerns over supplies from major exporters Iran and Nigeria.

ITC advanced over 2% to Rs 171, and Maruti advanced nearly 2% at Rs 823. Reliance Communications ended up 1.7% to Rs 505, and SBI added 1.5% to Rs 1,345. HDFC was up over 1% at Rs 1,720.

Decliners

Auto makers were lower today. Tata Motors declined 2.5% to Rs 725. During trading hours on May 18 2007, Tata Motors posted a 25.57% increase in consolidated net profit to Rs 2,169.99 crore in the fiscal 2007 compared with Rs 1,728.09 crore in the fiscal 2006. Bajaj Auto slid 1.7% to Rs 2,248 and Hero Honda was off nearly 1% at Rs 680.

Bajaj Auto shares plunged 16% in the past two sessions after the surprise revelation that Allianz — Bajaj partnership in its two insurance ventures has a call option to buy up to 74% at a nominal price. This was the greatest disappointment in the demerger plan Bajaj is considering.

IT stocks declined on a strong rupee. Wipro and Satyam shed 1.7% each to Rs 535 and Rs 448, respectively. TCS and Infosys lost over 1% each to Rs 1,237 and Rs 1,961, respectively.


[R]6:30AM European stocks are mixed Monday with M&A at the center of attention.[/R]

European markets were mixed Monday. In Germany the Xetra Dax added 15.6 points or 0.2% to 7,623.06 but in Paris, the French CAC 40 fell 16.5 points, or 0.3%, to 6,084.6 and the U.K. FTSE 100 index inched down 0.2% at 6,628.90.

Advancers

Acciona was also in focus, adding 5.9% as Citigroup said the Spanish construction company transformation was being overlooked by the market as they upgraded their recommendation from hold to buy and raised their price target.

German conglomerate Siemens contributed to the industrial sector gains by rising 1.6% in Frankfurt after it turned to an outsider, Merck & Co. executive Peter Loescher, to become its next chief executive.

Bayer rose 5.1%, helped by UBS raising its price target and a buy recommendation reiterated.
Back | Continue..

 

 
About Us | Contact Us | Privacy Policy | Disclaimer

©1999-2008 123jump.com. All rights reserved